Geneva, Aug. 6 -- International Clinical Trials Registry received information related to the study (ACTRN12626000947303) titled 'Study to evaluate the safety, effects, and early effectiveness of IDB-1... Read More
Geneva, Aug. 6 -- International Clinical Trials Registry received information related to the study (ISRCTN90696311) titled 'Combining virtual patients with simulation-based education: does order matte... Read More
Geneva, Aug. 6 -- International Clinical Trials Registry received information related to the study (ISRCTN16868733) titled 'Weight cHange for people with sErious mEntal iLlness' on July 30. Study Typ... Read More
Geneva, Aug. 6 -- International Clinical Trials Registry received information related to the study (ISRCTN10547630) titled 'Comparison of two methods of blood cardioplegia delivery during coronary art... Read More
Geneva, Aug. 6 -- International Clinical Trials Registry received information related to the study (ISRCTN12780992) titled 'Absorption comparisons between formulations' on July 30. Study Type: Interv... Read More
Geneva, Aug. 6 -- International Clinical Trials Registry received information related to the study (ACTRN12626000942358) titled 'A study comparing two interventions to support people concerned about a... Read More
Geneva, Aug. 6 -- International Clinical Trials Registry received information related to the study (ACTRN12626000941369) titled 'The RECOVER Trial: Restoring Energy and Capacity in Older adults via ag... Read More
Geneva, Aug. 6 -- International Clinical Trials Registry received information related to the study (ISRCTN71020313) titled 'Study to improve hemoglobin and assess fatigue in agricultural women workers... Read More
Geneva, Aug. 6 -- International Clinical Trials Registry received information related to the study (ChiCTR2600129062) titled 'The efficacy and safety of sequential IL-12/23p40 inhibitor and IL-17A inh... Read More
Geneva, Aug. 6 -- International Clinical Trials Registry received information related to the study (ChiCTR2600129066) titled 'Becotatug Vedotin combined with immune checkpoint inhibitors and gemcitabi... Read More